E
Evan J. Anderson
Researcher at Emory University
Publications - 283
Citations - 19308
Evan J. Anderson is an academic researcher from Emory University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 40, co-authored 217 publications receiving 11203 citations. Previous affiliations of Evan J. Anderson include Children's Memorial Hospital & Northwestern University.
Papers
More filters
Journal ArticleDOI
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
Alicia T. Widge,Nadine Rouphael,Lisa A. Jackson,Evan J. Anderson,Paul C. Roberts,Mamodikoe Makhene,James D. Chappell,Mark R. Denison,Laura J. Stevens,Andrea J. Pruijssers,Adrian B. McDermott,Britta Flach,Bob C. Lin,Nicole A. Doria-Rose,Sijy O'Dell,Stephen D. Schmidt,Kathleen M. Neuzil,Hamilton Bennett,Brett Leav,Mat Makowski,Jim Albert,Kaitlyn Cross,Venkata Viswanadh Edara,Katharine Floyd,Mehul S. Suthar,Wendy Buchanan,Catherine J. Luke,Julie E. Ledgerwood,John R. Mascola,Barney S. Graham,John H. Beigel +30 more
TL;DR: A small number of adults received two 100-μg injections of Moderna’s mRNA SARS-CoV-2 vaccine, and serum anti–spike protein and neutralizing antibody titers revealed immunogenicity and safety concerns.
Journal ArticleDOI
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
Nicole A. Doria-Rose,Mehul S. Suthar,Mat Makowski,Sarah O’Connell,Adrian B. McDermott,Britta Flach,Julie E. Ledgerwood,John R. Mascola,Barney S. Graham,Bob C. Lin,Sijy O'Dell,Stephen D. Schmidt,Alicia T. Widge,Venkata Viswanadh Edara,Evan J. Anderson,Evan J. Anderson,Lilin Lai,Katharine Floyd,Nadine Rouphael,Veronika I. Zarnitsyna,Paul C. Roberts,Mamodikoe Makhene,Wendy Buchanan,Catherine J. Luke,John H. Beigel,Lisa A. Jackson,Kathleen M. Neuzil,Hamilton Bennett,Brett Leav,Jim Albert,Pratap Kunwar +30 more
TL;DR: A total of 33 participants who received both doses of the Moderna mRNA-1273 vaccine against SARS-CoV-2 had blood drawn over a period of 6 months.
Journal ArticleDOI
Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)
Lindsay Kim,Lindsay Kim,Shikha Garg,Shikha Garg,Alissa O’Halloran,Michael Whitaker,Michael Whitaker,Huong Pham,Evan J. Anderson,Evan J. Anderson,Isaac Armistead,Nancy M. Bennett,Laurie M Billing,Kathryn Como-Sabetti,Mary Hill,Sue Kim,Maya Monroe,Alison Muse,Arthur Reingold,William Schaffner,Melissa Sutton,H. Keipp Talbot,Salina Torres,Kimberly Yousey-Hindes,Rachel Holstein,Rachel Holstein,Charisse N Cummings,Lynnette Brammer,Aron J. Hall,Alicia M Fry,Gayle E Langley +30 more
TL;DR: Aggressive implementation of prevention strategies, including social distancing and rigorous hand hygiene, may benefit the population as a whole, as well as those at highest risk for COVID-19-related complications.
Journal ArticleDOI
Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020.
Lindsay Kim,Michael Whitaker,Alissa O’Halloran,Anita Kambhampati,Shua J Chai,Arthur Reingold,Isaac Armistead,Breanna Kawasaki,James Meek,Kimberly Yousey-Hindes,Evan J. Anderson,Evan J. Anderson,Kyle P Openo,Andy Weigel,Patricia Ryan,Maya Monroe,Kimberly Fox,Sue Kim,Ruth Lynfield,Erica Bye,Sarah Shrum Davis,Chad Smelser,Grant Barney,Nancy L Spina,Nancy M. Bennett,Christina B Felsen,Laurie M Billing,Jessica Shiltz,Melissa Sutton,Nicole West,H. Keipp Talbot,William Schaffner,Ilene Risk,Andrea Price,Lynnette Brammer,Alicia M. Fry,Aron J. Hall,Gayle E Langley,Shikha Garg,Shikha Garg,Covid-Net Surveillance Team +40 more
TL;DR: The cumulative rate of pediatric COVID-19-associated hospitalization remains low compared with that among adults, but weekly rates increased during the surveillance period, and one in three hospitalized children were admitted to the ICU, similar to the proportion among adults.
Journal ArticleDOI
Rapid generation of neutralizing antibody responses in COVID-19 patients
Mehul S. Suthar,Mehul S. Suthar,Matthew G. Zimmerman,Matthew G. Zimmerman,Robert C. Kauffman,Grace Mantus,Susanne L. Linderman,William H. Hudson,Abigail Vanderheiden,Abigail Vanderheiden,Lindsay E. Nyhoff,Carl W. Davis,Oluwaseyi Adekunle,Maurizio Affer,Melanie A. Sherman,Stacian Reynolds,Hans Verkerke,David Alter,Jeannette Guarner,Janetta Bryksin,Michael Horwath,Connie M. Arthur,Natia Saakadze,Geoffrey H. Smith,Srilatha Edupuganti,Erin M. Scherer,Kieffer Hellmeister,Andrew Cheng,Juliet A. Morales,Andrew S. Neish,Sean R. Stowell,Filipp Frank,Eric A. Ortlund,Evan J. Anderson,Vineet D. Menachery,Nadine Rouphael,Aneesh K. Mehta,David S. Stephens,Rafi Ahmed,John D. Roback,Jens Wrammert +40 more
TL;DR: A cross-sectional study of antibody responses to the receptor-binding domain (RBD) of the spike protein and virus neutralization activity in a cohort of 44 hospitalized COVID-19 patients, which has implications for understanding protective immunity against SARS-CoV-2, therapeutic use of immune plasma, and development of much-needed vaccines.